Anabolic Bridge By 1st Phorm Overview & Drug Interactions

Check For Interactions With Anabolic Bridge

Supplement: Anabolic Bridge by 1st Phorm

Anabolic Bridge Label Images

This product contains

Below is a list of the 'active' ingredients listed on the supplement label for this product.

For a list of 'other ingredients', such as fillers, please see the 'Label Information' section on this page.

Drugs that interact with Anabolic Bridge by 1st Phorm

Below is a list of drug interactions for each ingredient in this supplement product. Please note that a supplement product may contain more than one ingredient that has interactions.

Label Information

Supplement Facts:

Daily Value (DV) Target Group(s): Adults and children 4 or more years of age
Minimum serving Sizes:
8 Capsule(s)
Maximum serving Sizes:
8 Capsule(s)
Servings per container 30

Ingredient Amount per Serving Group % DV, Adults & children 4+ years
Niacin
100 mg
Niacin 500%
Vitamin B6
20 mg
Vitamin B6 1000%
Vitamin B12
60 mcg
Vitamin B12 1000%
Leucine
1116 mg
Leucine
Lysine
932 mg
Lysine
Phenylalanine
924 mg
Phenylalanine
Threonine
884 mg
THREONINE
Valine
692 mg
Valine
Histidine
656 mg
Histidine
Isoleucine
608 mg
Isoleucine
Methionine
188 mg
METHIONINE

Other Ingredients:


Label Statments:


Formulation
- Ultra anabolic muscle protein synthesis activator
- Maximize muscle protein synthesis Accelerate muscle growth Stimulate peak amino acid levels
General Statements
- Nothing compares
FDA Statement of Identity
- Dietary Supplement

Brand Information

Manufacturer
Name 1st Phorm

Return to the main supplement interaction checker page

Parts of this content are provided by the Therapeutic Research Center, LLC and the Dietary Supplement Label Database.

DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.

© 2021 Therapeutic Research Center, LLC

Drug descriptions are provided by MedlinePlus.